Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Complete Submissions Are Key To Good Review Management Principles – FDA

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

As FDA rolls out its Good Review Management Principles – its attempt to improve FDA’s timely review of drug applications through professional best practices – the agency is stressing the importance of sponsors submitting complete applications to facilitate this process.

You may also be interested in...



Fast Track Speeds Approval, Tufts Finds; Therapeutic Category Also Key

FDA’s fast track program may be the most successful of FDA’s user fee-era regulatory initiatives aimed at speeding new drug reviews, an analysis by the Tufts Center for the Study of Drug Development suggests.

CDER, ORA To Be Major Beneficiaries Of Speedier FDA Hiring Process

As Congress debates increased funding and other steps to improve FDA oversight of imported drugs, the agency plans to hire 1,317 people in the next six months to bring staff numbers up to their full authorized levels

FDA Misses User Fee Goals As Resources Tighten For Application Reviews, SPAs

With the ink of the reauthorized Prescription Drug User Fee Act still drying, FDA is signaling that it may be some time before the agency will consistently meet the performance goals of its user fee program

Related Content

Topics

UsernamePublicRestriction

Register

PS003875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel